Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15 participants
OBSERVATIONAL
2017-09-22
2018-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Double Balloon Interventional Platform (DiLumen) for Complex Colonic ESD
NCT03846609
Prospective Study of a New Endolumenal Device Used During Endoscopic Polypectomy in the Colon
NCT04657601
Synergistic Effect of G-Eye Balloon for Behind the Folds Visualization With CADe (Discovery System) on Adenoma Detection Rate.
NCT05220345
Panoramic Screening by Complete Colonoscopy in the Management of Colorectal Adenomas
NCT03961893
Detection and Classification of Colon Polyps
NCT00825292
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The DiLumen™ Endolumenal Interventional Platform is a non-sterile, single-use, close-fitting sleeve that fits securely over a standard endoscope to stabilize it in the large intestine, and facilitates use of the endoscope for optical visualization, diagnosis, and treatment. The device is indicated to ensure complete positioning of an endoscope in the large intestine and assist with optical visualization, diagnosis, and endoscopic treatment.
The device received 510k clearance on Dec 6, 2016. The study will evaluate performance of the device during routine, scheduled, endoscopic polyp removal for these large polyps.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Endoscopic procedure
A double balloon endoscopic platform will be used during an ESD procedure
Double Balloon Endoluminal Platform
A DBA platform will be use din this registry study to facilitate ESD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Double Balloon Endoluminal Platform
A DBA platform will be use din this registry study to facilitate ESD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subjects scheduled for endoscopic removal of suspected complex adenomatous polyps in the large intestine which are sessile or polypoid lesions ≥ 2cm, near the ileocecal valve, dentate line, over a fold, or at a flexure; and or lesions tethered to the colon wall due to previous incomplete resection
* Subjects willing and able to give informed consent
* Subjects who in the opinion of the Principal Investigator have no medical contraindication to endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD)
Exclusion Criteria
* Subjects with a history of open or laparoscopic colorectal surgery
* Subjects with a history of Inflammatory Bowel Disease (IBD)
* Subjects with a suspected malignancy on polyp assessment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lumendi, LLC
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stavros Stavropoulos, MD
Role: PRINCIPAL_INVESTIGATOR
Winthrop-NYU Langone Mineola, NY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Winthrop-NYU Langone
Mineola, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DD-017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.